Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Ling Sun in
Google Scholar
PubMed
Search for other papers by Wenwu Zhu in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Ailin Zou in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Lipeng Mao in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Boyu Chi in
Google Scholar
PubMed
Search for other papers by Jianguang Jiang in
Google Scholar
PubMed
Search for other papers by Xuejun Zhou in
Google Scholar
PubMed
Search for other papers by Qingjie Wang in
Google Scholar
PubMed
Search for other papers by Fengxiang Zhang in
Google Scholar
PubMed
after AKI onset. Serum TSH level was tested by enhanced chemiluminescence assay ( 21 ). The reference range was 3.1–6.8 pmol/L for FT3, 12–22 pmol/L for free thyroxine (FT4), and 0.27–4.2 µIU/mL for TSH in adults. Hyperthyroidism was diagnosed as
Search for other papers by Elizabeth J de Koster in
Google Scholar
PubMed
Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Division of Clinical Studies, Institute of Cancer Research, London, UK
Search for other papers by Olga Husson in
Google Scholar
PubMed
Search for other papers by Eveline W C M van Dam in
Google Scholar
PubMed
Search for other papers by G Sophie Mijnhout in
Google Scholar
PubMed
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands
Department of Biomedical Sciences and Humanitas Clinical and Research Centre, Department of Nuclear Medicine, Humanitas University, Milan, Italy
Search for other papers by Wim J G Oyen in
Google Scholar
PubMed
Search for other papers by Marieke Snel in
Google Scholar
PubMed
Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands
Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands
Search for other papers by Lioe-Fee de Geus-Oei in
Google Scholar
PubMed
Search for other papers by Dennis Vriens in
Google Scholar
PubMed
Search for other papers by for the EfFECTS trial study group in
Google Scholar
PubMed
3, 6, and 12 months relative to baseline. The ThyPRO composite QoL score showed worse HRQoL at 3 months as compared to baseline. Finally, an unexpected increase in hyperthyroid symptoms was observed at 12 months as compared to baseline in patients
Search for other papers by Jakub Supronik in
Google Scholar
PubMed
Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
Search for other papers by Adam Kretowski in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
autoimmune thyroid disease (ATD). It is mainly associated with Graves’ disease (GD) but may also be seen in patients with chronic lymphocytic thyroiditis. Most commonly, it accompanies hyperthyroidism, but it may also occur in euthyroid patients, preceding
Search for other papers by Huixing Liu in
Google Scholar
PubMed
Search for other papers by Daoquan Peng in
Google Scholar
PubMed
stimulate carnitine palmitoyltransferase Iα (CPT1A), a rate-limiting β-oxidation enzyme ( 40 ). Accordingly, CPT1A mRNA and enzyme activity in the hyperthyroidism animal livers increase significantly ( 41 ); CPT1A is inhibited in the hypothyroidism mice ( 42
Search for other papers by Ru-Xuan Zhao in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Sha Luo in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
group, 24 patients were considered to be hyperthyroid and another 24 to be euthyroid at the time of assessment, and only patients in the former category were treated with antithyroid drugs. Thyroid function in the control group matched that in the active
Search for other papers by Xiaowen Zhang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Drum Tower Clinical Medical College, Southeast University, Nanjing, China
Search for other papers by Chen Han in
Google Scholar
PubMed
Search for other papers by Hongwei Wang in
Google Scholar
PubMed
Search for other papers by Xinghong Sun in
Google Scholar
PubMed
Search for other papers by Xin Dou in
Google Scholar
PubMed
Search for other papers by Xueying He in
Google Scholar
PubMed
Search for other papers by Di Wu in
Google Scholar
PubMed
Search for other papers by Shanmei Shen in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Xinlin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Bi in
Google Scholar
PubMed
January 2018 to October 2021. GD was diagnosed based on hyperthyroidism associated with anti-thyrotrophic hormone (TSH) receptor autoantibodies (TRAb). TED was diagnosed by the ophthalmology department based on clinical ophthalmic examinations. TED
Search for other papers by Zhengrong Jiang in
Google Scholar
PubMed
Search for other papers by Linghong Huang in
Google Scholar
PubMed
Search for other papers by Lijun Chen in
Google Scholar
PubMed
Search for other papers by Jingxiong Zhou in
Google Scholar
PubMed
Search for other papers by Bo Liang in
Google Scholar
PubMed
Search for other papers by Xuefeng Bai in
Google Scholar
PubMed
Search for other papers by Lizhen Wu in
Google Scholar
PubMed
Search for other papers by Huibin Huang in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is an organ-specific autoimmune disease that commonly manifests as hyperthyroidism and diffuse goitre. The annual incidence of GD is 20–50 cases per 100,000 people worldwide ( 1 , 2 ). The GD phenotype is
Diabetes and Endocrine Unit, National Hospital, Kandy, Sri Lanka
Search for other papers by G Amiyangoda in
Google Scholar
PubMed
Search for other papers by C N Antonypillai in
Google Scholar
PubMed
Search for other papers by S S C Gunatilake in
Google Scholar
PubMed
Search for other papers by T T Weerathunge in
Google Scholar
PubMed
Search for other papers by D Ediriweera in
Google Scholar
PubMed
Search for other papers by S G P D Kosgallana in
Google Scholar
PubMed
Search for other papers by R D P Jayawardana in
Google Scholar
PubMed
Search for other papers by H A N D Thissera in
Google Scholar
PubMed
Search for other papers by W J Emalka in
Google Scholar
PubMed
Search for other papers by H U Daraniyagala in
Google Scholar
PubMed
FT4 values between cases and controls at all time intervals (0, 60, 120, 180, 240, and 300 min) as shown in plot (B) of Fig. 2 and Table 2 . No adverse events or symptoms of hyperthyroidism were reported, and heart rate and blood pressure
Search for other papers by Zherui Fu in
Google Scholar
PubMed
Search for other papers by Yi Lai in
Google Scholar
PubMed
Search for other papers by Qianfei Wang in
Google Scholar
PubMed
Search for other papers by Feng Lin in
Google Scholar
PubMed
Search for other papers by Jiaping Fang in
Google Scholar
PubMed
Hematology and Oncology 2015 13 3 – 6 . 2 Taylor PN Albrecht D Scholz A Gutierrez-Buey G Lazarus JH Dayan CM & Okosieme OE . Global epidemiology of hyperthyroidism and hypothyroidism . Nature Reviews Endocrinology 2018 14 301 – 316
Search for other papers by Yukari Maki in
Google Scholar
PubMed
Search for other papers by Kiyomi Horiuchi in
Google Scholar
PubMed
Search for other papers by Takahiro Okamoto in
Google Scholar
PubMed
America 2014 43 475 – 494 . ( https://doi.org/10.1016/j.ecl.2014.02.007 ) 15 Eustatia-Rutten CFA Corssmit EPM Pereira AM Frölich M Bax JJ Romijn JA Smit JWA . Quality of life in longterm exogenous subclinical hyperthyroidism and the